Skip to content

Screener

Eligibility screening

A Phase 3B Trial to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or En…

Sponsored by Sumitomo Pharma Switzerland GmbHStudy detailsClinicalTrials.gov

120 US sites in AL, AZ, CA, CO +23

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.